February 01, 2016

New York Takes the Lead in EPCS

NY State EPCS infogram_LI_1064x800 (1)Today, Surescripts released new data about its Electronic Prescribing of Controlled Substances (EPCS) solution, and how it’s helping New York tackle prescription drug abuse. In fact, prescribers in New York are adopting EPCS at five times the national rate of 5.8 percent. New York’s prescribers are embracing EPCS, and 27 percent of total prescribers are enabled to digitally prescribe controlled substances.

Surescripts’ Ken Whittemore, Senior Vice President of Professional and Regulatory Affairs, said, “Physicians in New York have done a really nice job in preparing for this change. Pharmacies have stepped up in a very big way as well. New York’s impressive adoption rate shows its healthcare community’s commitment to not only meeting the I-STOP mandate, but also recognizing one of the state’s most pressing and alarming healthcare challenges.”

I-STOP is the Internet System for Tracking Over-Prescribing (I-STOP) mandate, which requires that all prescriptions be transmitted electronically in New York by March 27, 2016.

The mandate, which was previously slated for March 27 of last year, was delayed due to political and industry concerns, as well as the Long Term Care market’s sense of unpreparedness.

Whittemore is hopeful that the gap in adoption will close quickly, especially as the steps to comply are similar to other processes physicians and pharmacies regularly deal with.

“There’s still time to implement and adopt EPCS, “said Whittemore. “It certainly takes a bit of work for prescribers to complete identity proofing and credentialing, but the process isn’t all that different from others in terms of time and effort. And the great part is, once it’s done, it’s done.”

Visit getEPCS.com to review the steps to enabling the electronic transmission of controlled substance prescriptions. 

YOU MIGHT ALSO LIKE

July 05, 2018

Key Technologies for Fighting Opioid Misuse are Gaining Traction

The statistics are staggering. According to the Centers for Disease Control and Prevention, the opioid epidemic now takes more lives in the U.S. than breast cancer. In addition, American life expectancy at birth declined for the second consecutive year in 2016 due to a dramatic 21 percent rise in the death rate from drug overdoses. Our nation has not experienced a two-year consecutive decline in life expectancy since the early 1960s as a result of an influenza epidemic. Even the worst mortality rate of the AIDS epidemic in 1993 caused American life expectancy to drop for just one year. Read more...

July 02, 2018

Maine Required E-Prescribing for Opioids Last Year—and the Results Are In

This time last year, Maine implemented legislation that requires electronic prescribing for opioids. At the time, Maine ranked 25th in the nation based on prescriber and pharmacist enablement and utilization of the technology, known as E-Prescribing for Controlled Substances (EPCS). Now the state is ranked third in the nation, with virtually all its pharmacies and more than half of all its prescribers enabled for the technology as of May 2018. New York leads the nation, having implemented a legislative requirement in 2016 that requires all prescriptions to be delivered electronically, including controlled substances. Read more...

June 20, 2018

Surescripts Supports Healthcare Leadership Council’s “Roadmap for Action” to Address Opioid Crisis

Today, Surescripts joined more than 70 healthcare organizations in supporting the Healthcare Leadership Council’s “Roadmap for Action” offering guidance for healthcare professionals, lawmakers and regulators to address the opioid crisis. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX